共 70 条
[1]
Rehak J(2008)Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities Curr Eye Res 33 111-131
[2]
Rehak M(2008)Retinal vein occlusion: an approach to diagnosis, systemic risk factors and management Intern Med J 38 904-910
[3]
Yau JW(2008)Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator Mol Ther 16 791-799
[4]
Lee P(1998)Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells Penn State Retina Research Group Diabetes 47 1953-1959
[5]
Wong TY(2009)A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the standard care vs corticosteroid for retinal vein occlusion (SCORE) study report 6 Arch Ophthalmol 127 1115-1128
[6]
Best J(2009)A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the standard care vs corticosteroid for retinal vein occlusion (SCORE) study report 5 Arch Ophthalmol 127 1101-1114
[7]
Jenkins A(2011)Sustained release intraocular drug delivery devices for treatment of uveitis J Ophthalmic Vis Res 6 317-329
[8]
Campochiaro PA(2011)Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant Invest Ophthalmol Vis Sci 52 80-86
[9]
Hafiz G(2011)Trabecular meshwork and lens partitioning of corticosteroids: implications for elevated intraocular pressure and cataracts Arch Ophthalmol 129 914-920
[10]
Shah SM(2006)Intravitreal triamcinolone acetonide: a change in a paradigm Ophthalmic Res 38 218-245